EGFR and cancer: Recent studies demonstrate that oncogenic signaling pathways such as PI3K/AKT/mTOR, the epidermal growth factor receptor (EGFR), Ras/MAPK, Notch, and Wnt/β-catenin, play a fundamental role in cancer therapy [37,38,39,40,41].